Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Maintenance of Abstinence in Alcoholism
NCT00082199Phase 4Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Apr 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in alcohol dependence, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Apr 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00082199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082199.